Liu Z, Wang Y, Zhang J, Ding J, Guo L, Cui D, Fei J
Shanghai Institute of Biological Sciences, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.
Neuroreport. 2001 Mar 26;12(4):699-702. doi: 10.1097/00001756-200103260-00017.
Orphanin FQ, also known as nociceptin (NC),is a well-known ligand for opioid receptor-like ORLI receptor. This heptadecapeptide was identified as potently inhibiting the uptake of rat dopamine transporter (rDAT) which is stably expressed in CHO cells (designated D8 cells). Further kinetic analysis proved that this occurs through competitive inhibition with an IC50 of about 1.9 microM. Orphanin FQ also inhibits [3H]dopamine uptake by rat striatal synaptosomes, which confirmed the effect of orphanin FQ on D8 cells. Orphanin FQ was also found to inhibit GABA transporter type I (GATI) but not the serotonin transporter. These results suggest that orphanin FQ is an endogenous antagonist of dopamine transport and that it affects locomotion and other activities at least partly by inhibiting dopamine transporter and directly affecting dopamine transmission or by inhibiting GABA transporter to indirectly change dopaimne transmission.
孤啡肽FQ,也被称为痛敏肽(NC),是一种众所周知的类阿片受体(ORL1受体)配体。这种十七肽被确定为能有效抑制稳定表达于CHO细胞(命名为D8细胞)中的大鼠多巴胺转运体(rDAT)的摄取。进一步的动力学分析证明,这是通过竞争性抑制发生的,半数抑制浓度(IC50)约为1.9微摩尔。孤啡肽FQ还抑制大鼠纹状体突触体对[3H]多巴胺的摄取,这证实了孤啡肽FQ对D8细胞的作用。还发现孤啡肽FQ抑制I型γ-氨基丁酸转运体(GAT1),但不抑制5-羟色胺转运体。这些结果表明,孤啡肽FQ是多巴胺转运的内源性拮抗剂,它至少部分地通过抑制多巴胺转运体和直接影响多巴胺传递,或通过抑制γ-氨基丁酸转运体来间接改变多巴胺传递,从而影响运动和其他活动。